Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China · Delayed Price · Currency is CNY 21.28
-0.25 (-1.16%)
Feb 2, 2026, 3:00 PM CST
SHA:603008 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 8,814 | 8,594 | 8,579 | 7,741 | 7,652 | 5,570 |
Other Revenue | 135.04 | 135.04 | 99.67 | 97.35 | 119.39 | 53.53 |
| 8,949 | 8,729 | 8,678 | 7,839 | 7,772 | 5,623 | |
Revenue Growth (YoY) | 4.23% | 0.58% | 10.71% | 0.86% | 38.21% | 15.43% |
Cost of Revenue | 5,903 | 5,803 | 5,713 | 5,317 | 5,295 | 3,729 |
Gross Profit | 3,047 | 2,926 | 2,966 | 2,522 | 2,477 | 1,894 |
Selling, General & Admin | 2,404 | 2,323 | 2,171 | 1,919 | 1,498 | 1,168 |
Research & Development | 169.36 | 162.16 | 179.85 | 191.49 | 183.22 | 124.6 |
Other Operating Expenses | 73.64 | 48.03 | 51.99 | 58.74 | 52.42 | 46.12 |
Operating Expenses | 2,663 | 2,555 | 2,454 | 2,187 | 1,787 | 1,399 |
Operating Income | 383.88 | 371.77 | 511.71 | 334.4 | 689.37 | 495.34 |
Interest Expense | -71.77 | -78 | -70.23 | -89.96 | -65.99 | -74.05 |
Interest & Investment Income | 13.07 | 29.69 | 43.93 | 36.42 | 74.18 | 13.46 |
Currency Exchange Gain (Loss) | 27.65 | 27.65 | 33.79 | 28.91 | -12.37 | -3.42 |
Other Non Operating Income (Expenses) | -15.55 | -9.17 | -5.21 | -6.62 | -4.81 | -7.55 |
EBT Excluding Unusual Items | 337.28 | 341.94 | 513.98 | 303.16 | 680.39 | 423.78 |
Gain (Loss) on Sale of Investments | 15.26 | 8.21 | -1.2 | -22.36 | 1.34 | -22.75 |
Gain (Loss) on Sale of Assets | -1.25 | 0.12 | -1.45 | -2.36 | -4.29 | 0.91 |
Asset Writedown | -26.83 | -23.72 | -1.34 | - | 0 | - |
Legal Settlements | - | - | - | - | - | -1.64 |
Other Unusual Items | 38.02 | 27.84 | 45.43 | 43.82 | 29.8 | 26.82 |
Pretax Income | 362.49 | 354.4 | 555.41 | 322.26 | 707.25 | 427.13 |
Income Tax Expense | 20.82 | 27.83 | 107.64 | 50.04 | 101.92 | 76.11 |
Earnings From Continuing Operations | 341.68 | 326.57 | 447.77 | 272.22 | 605.33 | 351.02 |
Minority Interest in Earnings | 4.87 | -4.21 | -18.9 | -34.67 | -46.58 | -37.62 |
Net Income | 346.54 | 322.36 | 428.87 | 237.55 | 558.75 | 313.4 |
Net Income to Common | 346.54 | 322.36 | 428.87 | 237.55 | 558.75 | 313.4 |
Net Income Growth | -16.24% | -24.83% | 80.54% | -57.49% | 78.29% | -17.61% |
Shares Outstanding (Basic) | 375 | 379 | 386 | 383 | 385 | 392 |
Shares Outstanding (Diluted) | 375 | 379 | 386 | 383 | 385 | 392 |
Shares Change (YoY) | -1.52% | -1.84% | 0.84% | -0.57% | -1.64% | 0.92% |
EPS (Basic) | 0.92 | 0.85 | 1.11 | 0.62 | 1.45 | 0.80 |
EPS (Diluted) | 0.92 | 0.85 | 1.11 | 0.62 | 1.45 | 0.80 |
EPS Growth | -14.94% | -23.42% | 79.03% | -57.24% | 81.25% | -18.37% |
Free Cash Flow | 595.15 | 425.19 | 680.4 | -13.25 | 211.54 | 527.61 |
Free Cash Flow Per Share | 1.59 | 1.12 | 1.76 | -0.04 | 0.55 | 1.35 |
Dividend Per Share | 0.800 | 0.520 | 0.500 | 0.080 | 0.280 | 0.250 |
Dividend Growth | 60.00% | 4.00% | 525.00% | -71.43% | 12.00% | 400.00% |
Gross Margin | 34.04% | 33.53% | 34.17% | 32.17% | 31.87% | 33.69% |
Operating Margin | 4.29% | 4.26% | 5.90% | 4.27% | 8.87% | 8.81% |
Profit Margin | 3.87% | 3.69% | 4.94% | 3.03% | 7.19% | 5.57% |
Free Cash Flow Margin | 6.65% | 4.87% | 7.84% | -0.17% | 2.72% | 9.38% |
EBITDA | 480.67 | 534.67 | 762.74 | 484.45 | 824.98 | 621.73 |
EBITDA Margin | 5.37% | 6.13% | 8.79% | 6.18% | 10.62% | 11.06% |
D&A For EBITDA | 96.79 | 162.89 | 251.03 | 150.05 | 135.6 | 126.38 |
EBIT | 383.88 | 371.77 | 511.71 | 334.4 | 689.37 | 495.34 |
EBIT Margin | 4.29% | 4.26% | 5.90% | 4.27% | 8.87% | 8.81% |
Effective Tax Rate | 5.74% | 7.85% | 19.38% | 15.53% | 14.41% | 17.82% |
Revenue as Reported | 8,949 | 8,729 | 8,678 | 7,839 | 7,772 | 5,623 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.